Showing results (1101-1110 of 1,325) with videos related to
Sort By:
Pageof 133
Tumori|May 2, 2018
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcomaDaniela Greto, Mauro Loi, Calogero Saieva, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 9, 2022
Safety of CDK4/6 inhibitors and concomitant radiation therapy in patients affected by metastatic breast cancerLuca Visani, Lorenzo Livi, Ivica Ratosa, et al.International Journal of Radiation Oncology, Biology, Physics|August 25, 2009
Accelerated partial breast irradiation with IMRT: new technical approach and interim analysis of acute toxicity in a phase III randomized clinical trialLorenzo Livi, Fabrizio Banci Buonamici, Gabriele Simontacchi, et al.Scientific Reports|July 27, 2016
Genetic variability in a frozen batch of MCF-7 cells invisible in routine authentication affecting cell functionAndre Kleensang, Marguerite M Vantangoli, Shelly Odwin-DaCosta, et al.Human Reproduction (Oxford, England)|April 11, 2018
Doctor-couple communication during assisted reproductive technology visitsD Leone, L Borghi, S Del Negro, et al.Radiation Research|August 2, 2018
Enhancement of Soft Tissue Sarcoma Cell Radiosensitivity by Poly(ADP-ribose) Polymerase-1 InhibitorsMonica Mangoni, Mariangela Sottili, Giulia Salvatore, et al.Radiation Oncology (London, England)|August 31, 2018
International validation of the EORTC QLQ-PRT20 module for assessment of quality of life symptoms relating to radiation proctitis: a phase IV studyGeorgia K B Halkett, Charles Adam Wigley, Samar M Aoun, et al.Journal of Geriatric Oncology|December 10, 2022
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapyGiulio Francolini, Giulio Frosini, Vanessa Di Cataldo, et al.Cancer Research|April 13, 2012
Mitigating age-related immune dysfunction heightens the efficacy of tumor immunotherapy in aged miceVincent Hurez, Benjamin J Daniel, Lishi Sun, et al.Frontiers in Oncology|April 7, 2023
Choline PET/CT in recurrent prostate cancerBeatrice Detti, Maria Grazia Carnevale, Sara Lucidi, et al.Pageof 133